Celyad Oncology Sa's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Celyad Oncology Sa's ROA in the fourth quarter of 2022?
Celyad Oncology Sa recorded a cumulative net loss of $-46 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on assets (ROA) of -282.54%.

However, within the Healthcare sector 1218 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from to 6255.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2022) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Total Assets Change	-44.01 %	-78.3 %	-78.3 %	-77.11 %	-78.3 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-46	-30	-30	-30	-30
Return On Assets (TTM)	-282.54 %	-163.17 %	-86.43 %	-58.78 %	-44.62 %
CYAD's Total Ranking	# 6255	#	#	#	# 5005
Total Assets (TTM) in million	10	18	18	19	18
Seq. Total Assets Change	-44.01 %	0 %	-5.89 %	6.26 %	-78.3 %
Seq. Net Income Change	-	-	-	-	-

CYAD's 5 Years Annual ROA >> Back to CYAD Management Effectiveness >> Compare CYAD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 598
Sector	# 1219
Overall	# 6044

Return On Assets Statistics
High	Average	Low
-26.03 %	-67.68 %	-207.62 %
(Dec 31 2020)		(Dec 31 2022)

Financial Statements
Celyad Oncology Sa's Assets	$ 10 million	CYAD's Balance sheet
Celyad Oncology Sa's Income	$ -46 million	Quarterly CYAD's Income Statement
CYAD's Income by Division		See CYAD's Income by Division

Annual Return On Assets	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018
Y / Y Total Assets Change	-78.3 %	22.86 %	-28.66 %	-7.45 %	31.11 %
Total Assets in million	18	83	67	94	102
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-46	-30	-19	-32	-42
Annual Return On Assets	-255.88 %	-35.97 %	-28.68 %	-34.05 %	-41.19 %

CYAD's 5 Years Annual ROA >> Back to CYAD Management Effectiveness >> Compare CYAD ROA to its Competitors

More Return On Assets Ratios
CYAD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYAD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYAD's Competitors
Subscribers only: Roa for Celyad Oncology Sa's Suppliers
Subscribers only: Return On Assets for CYAD's Customers

You may also want to know
CYAD's Roi	CYAD's Inventory Turnover Ratio	CYAD's Growth Rates	CYAD's Dividend Comparisons
	CYAD's Profitability Ratios	CYAD's Asset Turnover Ratio	CYAD's Dividend Growth
CYAD's Roe	CYAD's Valuation Ratios	CYAD's Financial Strength Ratios	CYAD's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector

ROA

Date modified: 2026-06-22T17:07:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.